QWQi Wang

Qi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qi Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Ling Liu

    Department of Neurosurgery, Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu China

    2 shared publications
  • Meixiong Cheng

    Department of Neurosurgery, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

    2 shared publications
  • Tian Zhang

    Department of Neurosurgery, Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu China

    2 shared publications
  • Zongze He

    Department of Neurosurgery, Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan, China

    2 shared publications
  • Bo Gong

    Department of Laboratory Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan, China

    1 shared publication
  • Chen Yang

    Department of Laboratory Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan, China

    1 shared publication

Latest Publications

  • Open Access

    A Risk Model Based on Ferroptosis‐Related Genes OSMR, G0S2, IGFBP6, IGHG2, and FMOD Predicts Prognosis in Glioblastoma Multiforme

    by Yaqiu Wu, Ling Liu, Zhili Li, Tian Zhang, Qi Wang, Meixiong Cheng

    Background: Glioblastoma multiforme (GBM) is a common and highly aggressive brain tumor with a poor prognosis. However, the prognostic value of ferroptosis‐related genes (FRGs) and their classification remains insufficiently studied.Objective: This study aims to explore the significance of ferroptosis classification and its risk model in GBM using multi‐omics approaches and to evaluate its potential in prognostic assessment.Methods: Ferroptosis‐related genes (FRGs) were retrieved from databases such as FerrDB. The TCGA‐GBM and CGGA‐GBM datasets were used as training and testing cohorts, respectively. Univariate Cox regression and LASSO regression analyses were performed to establish a risk model comprising five genes (OSMR, G0S2, IGFBP6, IGHG2, FMOD). A Meta‐analysis of integrated TCGA and GTEx data was conducted to examine the differential expression of these genes between GBM and normal tissues. Key gene protein expression differences were analyzed using CPTAC and HPA databases. Single‐cell RNA sequencing (scRNA‐seq) analysis was employed to explore the cell type‐specific distribution of these genes.Results: The five‐gene risk model demonstrated significant prognostic value in GBM. Meta‐analysis revealed distinct expression patterns of the identified genes between GBM and normal tissues. Protein expression analysis confirmed these differences. scRNA‐seq analysis highlighted the diverse distribution of these genes across different cell types, offering insights into their biological roles.Conclusion: The ferroptosis‐based risk model provides valuable prognostic insights into GBM and highlights potential therapeutic targets, emphasizing the biological significance of ferroptosis‐related genes in tumor progression.


  • Open Access

    LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes

    by Zongze He, Juan Long, Chen Yang, Bo Gong, Meixiong Cheng, Qi Wang, Jian Tang

    Glioma is one of the most commonly diagnosed brain malignancies with a high cancer-related death rate in humans. The prognosis of glioma patients is still unsatisfactory. In the present study, we attempted to identify lncRNAs and miRNAs that might be related to NF-κB-mediated epithelial-mesenchymal transition in glioma cells based on online microarray expression profiles, and investigate the specific effects of lncRNA-miRNA-mRNA axes on glioma cell phenotypes. Herein, we identified lncRNA DGCR5 as a downregulated lncRNA in glioma that was negatively regulated by NF-κB1 in an NF-κB1 RE-dependent manner. LncRNA DGCR5 overexpression significantly inhibited the capacity of glioma cells to proliferate, migrate, and invade, whereas promoted the apoptosis of glioma cells. Moreover, lncRNA DGCR5 overexpression upregulated the epithelial marker E-cadherin while downregulating the mesenchymal marker VIM, as well as Snai2 and TWIST. Regarding the underlying molecular mechanisms, lncRNA DGCR5 could inhibit miR-21 and miR-23a expression, and miR-21 or miR-23a overexpression significantly reversed the tumor-suppressive effects of lncRNA DGCR5 overexpression. LncRNA DGCR5 exerted its tumor-suppressive effects through the DGCR5/miR-21/Smad7 and DGCR5/miR-23a/PTEN axes. In conclusion, lncRNA DGCR5 suppresses the capacity of glioma cells to migrate and invade via miR-21/Smad7, whereas it inhibits the proliferation and enhances the apoptosis of glioma cells through miR-23a/PTEN.


  • Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas

    by Zongze He, Longyi Chen, Xiao Hu, Jian Tang, Linfu He, Junting Hu, Fan Fei, Qi Wang

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies